Pharmafile Logo

B2B sales

- PMLiVE

Diabetes management – should there be a ‘one-size fit all’ approach?

For Diabetes Awareness Week 2022, we discussed diabetes as a chronic condition, and the increasing importance of home-based disease management.

IGNIFI

- PMLiVE

Cannes Lions shows health creative is becoming an art form

Painting a portrait of health at this year’s Festival of Creativity – and the picture is looking good

- PMLiVE

The Power of AI in Medical Education

Artificial intelligence (AI) is a rapidly growing field with many applications in the world of medicine, including continuing medical education. Ritu Kumar, Medscape lead data scientist, explains how Medscape Education...

Medscape Education

- PMLiVE

FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease

Lecanmab is being evaluated in the ongoing phase 3 Clarity Alzheimer's clinical trial

- PMLiVE

New Swiss research reveals how Omicron evades the immune system

A team from the University of Geneva and the Geneva University Hospital analysed the antibody neutralisation capacity of 120 people previously infected with one of the different COVID-19 variants

- PMLiVE

Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021

Evoke KYNE took home the Communiqué Communications Consultancy of the Year award at the 2021 Communiqué Awards held on 1 September at the Grosvenor House hotel in London.David Kyne, CEO, Evoke KYNE said:...

Inizio

- PMLiVE

Michael Grela Elected President of the Society for Health Communication

February 8, 2022 – Michael Grela, Evoke KYNE’s EVP, Head of Reputation and Social Impact, has been elected President of the Society for Health Communication, a member-driven organization working to advance the science...

Inizio

- PMLiVE

Evoke Kyne Appoints Maureen Byrne to President and Promotes Four Executive Leaders

New York, April 27, 2022 – Evoke KYNE, an award-winning health communications agency, today announced the appointment of Maureen Byrne to President. Byrne will assume global leadership responsibilities from David Kyne including management of its...

Inizio

- PMLiVE

First evidence-based guide launched to put patients at heart of digital innovations

Produced by the University of Plymouth, the Academic Health Science Network and Boehringer Ingelheim, the guide follows the UK government’s plan to revolutionise digital health and social care

- PMLiVE

AstraZeneca acquires TeneoTwo in a deal worth up to $1.27bn

The acquisition includes TeneoTwo’s phase 1 clinical-stage T-cell engager

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links